| Dr Robert Smith, OD | |
|
4721 26th Ave, Meridian, MS 39305-4703 | |
| (601) 485-2020 | |
| (601) 581-1662 |
| Full Name | Dr Robert Smith |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 6 Years |
| Location | 4721 26th Ave, Meridian, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851872303 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 978 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Primary Eyecare And Optical Of Meridian, P.a. | 3577647064 | 4 |
News Archive
Beta-Pro LLC, announced today that it has expanded its operations to accommodate increasing demands from pharmaceutical drug discovery and research institutes in the $2 billion hepatocyte market. The human cellular sciences company now manages extensive laboratory facilities in the University of Virginia Research Park in Charlottesville, Virginia.
Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola.
The introduction of infliximab, the first biologic therapy approved for the treatment of inflammatory bowel diseases, did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario, according to a study published by authors from several Canadian hospitals and ICES in the journal Gut.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
By studying tumor cell behavior in a novel "scaffold-free" 3-D system, researchers have determined that the protein Pannexin1 may play an important biomechanical role in binding tissues together, an effect that is lost in cancerous cells.
› Verified 9 days ago
| Provider Name | Primary Eyecare & Optical Of Meridian, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578757076 PECOS PAC ID: 3577647064 Enrollment ID: O20080221000584 |
News Archive
Beta-Pro LLC, announced today that it has expanded its operations to accommodate increasing demands from pharmaceutical drug discovery and research institutes in the $2 billion hepatocyte market. The human cellular sciences company now manages extensive laboratory facilities in the University of Virginia Research Park in Charlottesville, Virginia.
Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola.
The introduction of infliximab, the first biologic therapy approved for the treatment of inflammatory bowel diseases, did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario, according to a study published by authors from several Canadian hospitals and ICES in the journal Gut.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
By studying tumor cell behavior in a novel "scaffold-free" 3-D system, researchers have determined that the protein Pannexin1 may play an important biomechanical role in binding tissues together, an effect that is lost in cancerous cells.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Smith, OD 4721 26th Ave, Meridian, MS 39305-4703 Ph: (601) 485-2020 | Dr Robert Smith, OD 4721 26th Ave, Meridian, MS 39305-4703 Ph: (601) 485-2020 |
News Archive
Beta-Pro LLC, announced today that it has expanded its operations to accommodate increasing demands from pharmaceutical drug discovery and research institutes in the $2 billion hepatocyte market. The human cellular sciences company now manages extensive laboratory facilities in the University of Virginia Research Park in Charlottesville, Virginia.
Researchers from Albert Einstein College of Medicine of Yeshiva University and other institutions have developed a potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola.
The introduction of infliximab, the first biologic therapy approved for the treatment of inflammatory bowel diseases, did not result in lower rates of hospitalizations or intestinal surgeries among patients living with IBD in Ontario, according to a study published by authors from several Canadian hospitals and ICES in the journal Gut.
Catherine Aaron and Gabrielle Beaudry were 17 when they knocked on the door of the laboratory of Alex Parker, a neuroscience researcher at the University of Montreal Hospital Research Centre. While students at Collège Jean-de-Brébeuf in Montreal, they were looking for a mentor for an after-school research project. Two and half years later, the results of this scientific adventure were published today in the Journal of Agricultural and Food Chemistry.
By studying tumor cell behavior in a novel "scaffold-free" 3-D system, researchers have determined that the protein Pannexin1 may play an important biomechanical role in binding tissues together, an effect that is lost in cancerous cells.
› Verified 9 days ago
Dr. Thi Bui, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1733 2nd St S, Meridian, MS 39301 Phone: 601-533-1355 Fax: 601-553-0527 | |
Dr. Eric J Johnson Ii, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 20th Ave, Meridian, MS 39301 Phone: 601-485-2368 Fax: 601-693-2174 | |
Dr. James Dewey Westbrook, OD Optometrist Medicare: Medicare Enrolled Practice Location: 910 23rd Ave, Meridian, MS 39301 Phone: 601-693-1841 | |
Primary Eyecare South Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1217 S Frontage Rd Ste E, Meridian, MS 39301 Phone: 601-485-2020 | |
Eyecare Express, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1733 2nd St S, Meridian, MS 39301 Phone: 601-553-0527 Fax: 601-553-1355 | |
David A Otto, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5002 Highway 39 N, Building B, Meridian, MS 39301 Phone: 601-483-7331 | |
Dr. Tracy B Phillips, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1733 2nd St S, Meridian, MS 39301 Phone: 601-693-0176 |